China news from FierceBiotech
NewsTraditional remedies offer opportunities, challenges
The Financial Times delves into the push to develop new therapeutics from traditional Chinese and Indian remedies. There have been successes, including the anti-malarial artemether, which was Read more...
Novartis' China plans grew from science roundtables
PharmAsia News sat down with Paul Herrling, head of corporate research at Novartis, and En Li, VP and head of research for Novartis Institutes for BioMedical Research Shanghai, to discuss the Read more...
Booming Chinese market lures Unigene joint venture
Unigene is racing to complete construction of new facilities in China that will house its joint venture with a Chinese pharma company. The joint venture plans to pursue R&D work as well as drug Read more...
Genzyme gets biosimilar rejection, builds R&D plant
The FDA have given a thumbs down to Genzyme's request for permission to sell its Pompe disease drug Read more...
ProGenTech gains $21M in third venture round
ProGenTech, with operations in California and China, has pocketed $21 million in its third round of venture financing. The biotech company markets products for research and medical diagnostics and is Read more...
India moves to back up emerging biotech industry
The Times of India lauds new efforts in the subcontinent to encourage the growth of its biotech Read more...
Forecast: BioPharma outsourcing will grow '08
Biotech and Big Pharma alike are taking outsourcing to new heights in 2008, according to IDC's Health Industry Insights report. This year everything from R&D to clinical trials and manufacturing Read more...
The low cost of doing business in China
A couple of days ago I made a small blunder on my way toward making a larger point. In summarizing a Wall Read more...
WuXi buyout deal raises questions on scientists' pay scale
The average scientist on WuXi PharmaTech's Chinese payroll earns about $30,000 a year, roughly 10 percent of what an American with the same qualifications would earn. Numbers like that make analysts Read more...
Indian developer inks R&D pact with Merck
China may have seized the spotlight in the Pacific Rim recently with a string of new research Read more...
| Press ReleasesStatement by Mike Leavitt Secretary of HHS on the United States-China Meetings Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety WASHINGTON, Sept. 14 -- The following is a statement by Mike Read more... PRESS RELEASE: AstraZeneca Enhances Clinical Research Capabilities in China With First Clinical Pharmacology Unit AstraZeneca Enhances Clinical Research Capabilities in China With First Clinical Pharmacology Unit AstraZeneca today announced a strategic partnership with Peking University 3rd Hospital to open its Read more... |
Get more China coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight